Seattle Genetics (SGEN)
49.85
+0.17 +0.34%
NASDAQ
Apr 23, 16:59
Delayed 2m
USD
View All Key Stats
SGEN Key Stats
| Income Statement | |
| Revenue (TTM) | 482.25M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.89 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -125.53M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 87.91% |
| Profit Margin (Quarterly) | -45.68% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 7.884B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.92 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 11.64 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -30.16M |
| Return on Equity (TTM) | Upgrade |
View All SGEN News
SGEN News
-
WireHeadlineTime (ET)
-
SA Breaking News04/20 07:43
-
Yahoo04/19 17:28
-
SA Breaking News04/19 08:35
-
MT Newswires04/12 08:23
-
Business Wire04/12 08:00
-
Yahoo04/05 08:08
-
Business Wire04/05 08:00
-
SA Breaking News04/04 06:06
-
Yahoo03/28 17:02
-
Yahoo03/27 09:01
View All Events
SGEN Events
| Date | Type | Description |
|---|---|---|
| 07/27/2018 | Misc | Seattle Genetics Inc Second Quarter Earnings Conference Call in 2018 |
| 07/27/2018 | Earnings | Seattle Genetics Inc Second Quarter Earnings Results in 2018 |
| 04/26/2018 16:30 EDT | Misc | Seattle Genetics Inc First Quarter Earnings Conference Call in 2018 |
| 04/26/2018 | Earnings | Seattle Genetics Inc First Quarter Earnings Results in 2018 |
| 03/09/2018 | Misc | Seattle Genetics Completes Acquisition of Cascadian Therapeutics |
| 02/15/2018 | Misc | Seattle Genetics Inc Annual Report in 2017 |
| 02/06/2018 16:30 EST | Misc | Seattle Genetics Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/06/2018 | Earnings | Seattle Genetics Inc Fourth Quarter Earnings Results in 2017 |
| 10/26/2017 16:30 EDT | Misc | Seattle Genetics Inc Third Quarter Earnings Conference Call in 2017 |
| 10/26/2017 | Earnings | Seattle Genetics Inc Third Quarter Earnings in 2017 Release |
SGEN Fundamentals
Income Statement View Statement
SGEN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
SGEN One Page Reports
- One Page Report Download
SGEN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 49.85 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.seattlegenetics.com
- Investor Relations URL: http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-IRHome
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Apr. 26, 2018
- Last Earnings Release: Feb. 06, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada.
SGEN Excel Add-In Codes
- Name: =YCI("SGEN","name")
- Description: =YCI("SGEN","description")
- Sector: =YCI("SGEN","sector")
- Industry: =YCI("SGEN","industry")
- Est. Current Fiscal Year End: =YCI("SGEN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other SGEN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SGEN Tweets Stocktwits
Advertisement
